TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT03463954: Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors

Sponsor: Novian Health Inc. · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 122 pts

Competing Trials Overlap

9 Active Trials

Excess Burn Exposure

$2,263,800

Rescue Site Savings

+$1,478,400

Unlock Full NCT03463954 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT03463954 Rescue Dossier →